CRL-3216
Wegovy (semaglutide) Wegovy is a GLP-1 agonist medication that is approved to: Aid in weight loss for adults and children over 12 years old who have obesity, or in adults who have overweight and have a weight-related health condition (such as high blood pressure, type 2 diabetes , or high cholesterol) Reduce the risk of major cardiovascular events, such as heart attack or stroke, in adults who have cardiovascular disease and have obesity or overweight Wegovy comes in a single-use pen that you inject once per week, either with or without food
These medications work by reducing hunger, slowing stomach emptying, and altering food preferences, which can lead to lower calorie intake and, in some cases, unintended side effects such as nausea, constipation, and loss of lean muscle mass
Retatrutide is a triple-hormone receptor agonist from Eli Lilly that produced 2428% average weight loss in Phase 2 trials, significantly exceeding the 1215% typical of semaglutide and the 1522% of tirzepatide
Some fibers are gentle and grounding, while others can cause gas or discomfortespecially when digestion is already slowed.* Psyllium Husk: A Gold Standard Fiber Psyllium husk, whether taken in capsule or whole husk form, is often considered to be the best fiber for GLP-1 users
By Graeme Walker Excellent service
